CFHR1 and hemolytic-uremic syndrome: Paradoxically, loss-of-function mutation or deletion of complement-protective CFHR1/3 (protective for AMD) is actually pathogenic in other conditions such as C3 glomerulopathy (54) and hemolytic uremic syndrome (HSU) (55).